Glass Jacobson Investment Advisors llc
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1964394
OWINGS MILLS, MD
Position in TAK
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$561
-$87 QoQ
Shares Held
35
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#361
of 375 holders
Holding Since
Dec 2022
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Glass Jacobson Investment Advisors llc holds $85,312 across 6 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,000 | $46,510 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
2,000 | $28,980 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
208 | $7,047 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
372 | $1,833 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
35 | $561 | |
| 6 | VTRS |
Viatris Inc
|
24 | $381 |
All Filings in TAK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $561 | 35 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $648 | 35 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $545 | 35 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $512 | 35 | Shares | Sole | 2025-10-29 | |
| 2023-06-30 | $1,052 | 67 | Shares | Sole | 2023-07-25 | |
| 2022-12-31 | $1,045 | 67 | Shares | Sole | 2023-02-06 | |
| No filing history on record for this holder in this stock. | ||||||